Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea

scientific article published in August 2002

Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1023/A:1019806411610
P698PubMed publication ID12240946

P2093author name stringAshim K Mitra
Banmeet S Anand
P2860cites workHuman intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localizationQ24317726
Drug transport and targeting. Intestinal transport.Q33878819
Transporter-mediated permeation of drugs across the blood-brain barrierQ34051724
Membrane transportersQ34061174
Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2.Q34121835
Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2Q34298240
Determination of acid surface pH in vivo in rat proximal jejunumQ34496469
Acyclovir transport by the human placentaQ34542399
Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteersQ34729029
Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissueQ35812095
Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic EfficacyQ40138670
Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell lineQ40763033
Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.Q40877910
Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell lineQ40965871
Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.Q41010097
Carrier-mediated intestinal transport of drugsQ41140046
Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugsQ43938182
Mechanism of acyclovir uptake in rat jejunumQ44153379
Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney.Q48068970
Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovirQ48932058
The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestineQ48953363
Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.Q50719104
Acyclovir in the treatment of herpetic stromal diseaseQ70664270
How peptides cross biological membranesQ70973750
Effect of acylation on the ocular disposition of acyclovir. I: Synthesis, physicochemical properties, and antiviral activity of 2'-estersQ72238878
Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitisQ72238880
Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elutionQ73073421
The influence of luminal pH on transport of neutral and charged dipeptides by rat small intestine, in vitroQ73202090
Characterization of an oligopeptide transporter in renal lysosomesQ73822227
Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cellsQ73891025
Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporterQ77357223
P433issue8
P921main subjectaciclovirQ147101
P304page(s)1194-1202
P577publication date2002-08-01
P1433published inPharmaceutical ResearchQ7180737
P1476titleMechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea
P478volume19

Reverse relations

cites work (P2860)
Q38995367A comprehensive insight on ocular pharmacokinetics
Q38904119Advances in the use of prodrugs for drug delivery to the eye.
Q44856650Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium
Q53594005Biotin uptake by rabbit corneal epithelial cells: role of sodium-dependent multivitamin transporter (SMVT).
Q39218343Characterization of the carrier-mediated transport of ketoprofen, a nonsteroidal anti-inflammatory drug, in rabbit corneal epithelium cells
Q36527751Chemical modification and formulation approaches to elevated drug transport across cell membranes
Q39647814Cinnamic esters of acyclovir-synthesis and biological activity
Q34779782Current prodrug strategies via membrane transporters/receptors
Q47578401Diclofenac/biodegradable polymer micelles for ocular applications
Q46399484Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies
Q34141933Evaluation of active and passive transport processes in corneas extracted from preserved rabbit eyes
Q44483643Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of acyclovir and idoxuridine
Q46799578Identification and characterization of a Na+-dependent neutral amino acid transporter, ASCT1, in rabbit corneal epithelial cell culture and rabbit cornea
Q53592834Identification and functional expression of a carrier-mediated riboflavin transport system on rabbit corneal epithelium.
Q36573373Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues
Q37850457In vitro cell culture models to study the corneal drug absorption
Q43298355Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment
Q36903801Novel approaches to retinal drug delivery
Q37103787Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity
Q44483641Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea
Q38065184Novel strategies for anterior segment ocular drug delivery
Q26851574Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition
Q30475605Ocular drug delivery
Q42105578Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections
Q39557119Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir
Q36316835Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters
Q42170327Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats
Q36939218Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.
Q35950189Prodrug approach to improve absorption of prednisolone
Q38005228Prodrug strategies in ocular drug delivery
Q37256549Recent perspectives in ocular drug delivery
Q40941028Small Neutral Amino Acid Ester Prodrugs of Acyclovir Targeting Amino Acid Transporters on the Cornea: Possible Antiviral Agents Against Ocular HSV-1 Infections
Q44466742Synthesis and characterization of novel dipeptide ester prodrugs of acyclovir
Q39332407Targeted lipid based drug conjugates: a novel strategy for drug delivery.
Q51937395Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.
Q37147862Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement
Q45004828Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB(0,+).
Q35116134Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies
Q35990861mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs